Pushing The Limits

Welcome to an episode where we explore the cutting-edge world of photobiomodulation (PBM) and its potential to transform the landscape of neurodegenerative disease treatment. This episode features an in-depth interview with Liam Pingree, CEO of Neuronic, we dive into the science behind PBM and the innovative Neuradiant 1070 device. Building on our discussion from last year, we’ll uncover how this non-invasive therapy leverages red and near-infrared light to enhance brain health, with a focus on conditions like Alzheimer’s and Parkinson’s. Photobiomodulation, often called low-level laser or red light therapy, is gaining traction as a promising approach to tackle the mitochondrial dysfunction and inflammation that drive neurodegenerative diseases. Today, we’ll hear from Liam about how the Neuradiant 1070, with its unique 1070 nm wavelength, aims to penetrate deeper into the brain, offering hope for symptom relief and possibly slowing disease progression. We’ll also spotlight the contributions of key researchers